IL-18 Reconstitutes Vg9Vd2 T Cells in HIV plus Patient Samples

被引:0
|
作者
Murday, Alanna [1 ]
Pauza, C. David [1 ]
机构
[1] Ihv, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P-D10
引用
收藏
页码:93 / 93
页数:1
相关论文
共 48 条
  • [31] 'Bystander polarization' of CD4+ T cells:: activation with high-dose IL-2 renders naive T cells responsive to IL-12 and/or IL-18 in the absence of TCR ligation
    Chakir, H
    Lam, DKY
    Lemay, AM
    Webb, JR
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (07) : 1788 - 1798
  • [32] Expressing IL-15/IL-18 and CXCR2 improve infiltration and survival of EGFRvIII-targeting CAR-T cells in breast cancer
    Sun, Ruixin
    Liu, Yifan
    Wu, Chuanlong
    Zhou, Min
    Luo, Hong
    Du, Guoxiu
    Liu, Zhengyang
    Sun, Yansha
    Dong, Yiwei
    Su, Jingwen
    Fan, Mingliang
    Shi, Bizhi
    Jiang, Hua
    Li, Zonghai
    BIOCHEMICAL PHARMACOLOGY, 2023, 212
  • [33] Skewed expression and up-regulation of the IL-12 and IL-18 receptors in resting and activated CD4 T cells from HIV-1-infected patients
    de Arquer, Guillermo Robert
    Pena, Ruth
    Cabrera, Cecilia
    Coma, Gemma
    Ruiz-Hernandez, Raul
    Guerola, Rosa
    Clotet, Bonaventuta
    Ruiz, Lidia
    Este, Jose A.
    Calle, M. Luz
    Bofill, Margarita
    JOURNAL OF LEUKOCYTE BIOLOGY, 2007, 82 (01) : 72 - 78
  • [34] Preclinical development of CAR T cells with antigen-inducible IL-18 enforcement to treat GD2-positive solid cancers
    Fischer-Riepe, Lena
    Kailayangiri, Sareetha
    Zimmermann, Katharina
    Pfeifer, Rita
    Aigner, Michael
    Altvater, Bianca
    Kretschmann, Sascha
    Voelkl, Simon
    Hartley, Jordan
    Dreger, Celine
    Petry, Katja
    Bosio, Andreas
    von Doellen, Angelika
    Hartmann, Wolfgang
    Lode, Holger
    Goerlich, Dennis
    Mackensen, Andreas
    Jungblut, Melanie
    Schambach, Axel
    Abken, Hinrich
    Rossig, Claudia
    CANCER RESEARCH, 2024, 84 (06)
  • [35] Erratum: Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα
    I-K Choi
    J-S Lee
    S-N Zhang
    J Park
    C H Sonn
    K-M Lee
    C-O Yun
    Gene Therapy, 2011, 18 : 942 - 942
  • [36] Administration of IL-2 and IL-18 with anti-PD-L1 Ab suppresses liver tumor by early memory CD8 T cells
    Kimura, Kiminori
    Tanaka, Yoshimasa
    Kohara, Michinori
    CANCER SCIENCE, 2024, 115 : 1597 - 1597
  • [37] Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα (vol 18, pg 898, 2011)
    Choi, I-K
    Lee, J-S
    Zhang, S-N
    Park, J.
    Sonn, C. H.
    Lee, K-M
    Yun, C-O
    GENE THERAPY, 2011, 18 (09) : 942 - 942
  • [38] LMP2A-targeting CAR-T cells and TRUCKs with inducible expression of IL-12 or IL-18 as promising tool to treat various EBV-associated malignancies
    Thoelke, S.
    Dragon, A. C.
    Bonifacius, A.
    Zimmermann, K.
    Malinconico, C.
    Maecker-Kolhoff, B.
    Blasczyk, R.
    Schambach, A.
    Eiz-Vesper, B.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 359 - 360
  • [39] Expressing IL-15/IL-18 and CXCR2 improve infiltration and survival of EGFRvIII-targeting CAR-T cells in breast cancer (vol 212, 115536, 2023)
    Sun, Ruixin
    Liu, Yifan
    Wu, Chuanlong
    Zhou, Min
    Luo, Hong
    Du, Guoxiu
    Liu, Zhengyang
    Sun, Yansha
    Dong, Yiwei
    Su, Jingwen
    Fan, Mingliang
    Shi, Bizhi
    Jiang, Hua
    Li, Zonghai
    BIOCHEMICAL PHARMACOLOGY, 2023, 214
  • [40] The costimulatory effect of IL-18 on the induction of antigen-specific IFN-γ production by resting T cells is IL-12 dependent and is mediated by up-regulation of the IL-12 receptor β2 subunit
    Chang, JT
    Segal, BM
    Nakanishi, K
    Okamura, H
    Shevach, EM
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2000, 30 (04) : 1113 - 1119